Clinical Trials Directory

Trials / Completed

CompletedNCT02455050

A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
79 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.

Conditions

Interventions

TypeNameDescription
DRUGCarboxymethylcellulose Sodium Based Eye Drops1 to 2 drops of Carboxymethylcellulose Sodium Based Eye Drops \[New Eye Drop Formula\] in each eye.
DRUGSystane® Gel Drops1 to 2 drops of Systane® Gel Drops in each eye.
DRUGGenteal® Lubricant Gel Drops1 to 2 drops of Genteal® Lubricant Gel Drops in each eye.

Timeline

Start date
2014-12-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2015-05-27
Last updated
2017-01-04
Results posted
2017-01-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02455050. Inclusion in this directory is not an endorsement.

A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to S (NCT02455050) · Clinical Trials Directory